Cargando…

Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome

BACKGROUND: MicroRNAs (miRNAs) serve as important regulators of inflammatory and immune responses and are implicated in several immune disorders including gouty arthritis. The expression of miR-146a is upregulated in the peripheral blood mononuclear cells of patients with inter-critical gout when co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Quan-Bo, Qing, Yu-Feng, Yin, Cong-Cong, Zhou, Li, Liu, Xian-shuang, Mi, Qing-Sheng, Zhou, Jing-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855987/
https://www.ncbi.nlm.nih.gov/pubmed/29544526
http://dx.doi.org/10.1186/s13075-018-1546-7
_version_ 1783307225843892224
author Zhang, Quan-Bo
Qing, Yu-Feng
Yin, Cong-Cong
Zhou, Li
Liu, Xian-shuang
Mi, Qing-Sheng
Zhou, Jing-Guo
author_facet Zhang, Quan-Bo
Qing, Yu-Feng
Yin, Cong-Cong
Zhou, Li
Liu, Xian-shuang
Mi, Qing-Sheng
Zhou, Jing-Guo
author_sort Zhang, Quan-Bo
collection PubMed
description BACKGROUND: MicroRNAs (miRNAs) serve as important regulators of inflammatory and immune responses and are implicated in several immune disorders including gouty arthritis. The expression of miR-146a is upregulated in the peripheral blood mononuclear cells of patients with inter-critical gout when compared to normouricemic and hyperuricemic controls and those patients with acute gout flares. However, the role of miR-146a in the development of gout remains unknown. Here, we used miR-146a knockout (KO) mice to test miR-146a function in a monosodium urate (MSU)-induced gouty arthritis model. METHODS: The footpad or ankle joint of miR-146a KO and wild-type (WT) mice were injected with an MSU suspension to induce acute gouty arthritis. Bone marrow-derived macrophages (BMDMs) were stimulated with MSU and the gene expression of miR-146a; interleukin 1 beta (IL-1β); tumor necrosis factor-α (TNF-α); and the NACHT, LRR and PYD domains-containing protein 3 (NALP3) inflammasome was evaluated. TNF-α and IL-1β protein levels in BMDMs were assessed by fluorescence-activated cell sorting and western blot analyses. Gene and protein levels of TNF receptor-associated factor 6 (TRAF6) and IL-1 receptor-associated kinase (IRAK1), the targets of miR-146a, were also measured. RESULTS: Significantly increased paw swelling and index and ankle joint swelling were observed in miR-146a KO mice compared to WT controls after MSU treatment. MiR-146a expression in BMDMs from WT mice was dramatically upregulated at 4 h following MSU stimulation. Additionally, the expression of IL-1β, TNF-α, and NALP3 was higher in BMDMs from miR-146a KO mice after exposure to MSU crystals compared to those from WT mice. Consistent with the observed gene expression, the IL-1β and TNF-α proteins were upregulated in miR-146a KO mice. Additionally quantitative RT-PCR and western blot demonstrated that TRAF6 and IRAK1 were dramatically upregulated in BMDMs from miR-146 KO mice compared to those from WT mice. CONCLUSIONS: Collectively, these observations suggest that miR-146a provides negative feedback regulation of gouty arthritis development and lack of miR-146a enhances gouty arthritis via upregulation of TRAK6, IRAK-1, and the NALP3 inflammasome function.
format Online
Article
Text
id pubmed-5855987
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58559872018-03-22 Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome Zhang, Quan-Bo Qing, Yu-Feng Yin, Cong-Cong Zhou, Li Liu, Xian-shuang Mi, Qing-Sheng Zhou, Jing-Guo Arthritis Res Ther Research Article BACKGROUND: MicroRNAs (miRNAs) serve as important regulators of inflammatory and immune responses and are implicated in several immune disorders including gouty arthritis. The expression of miR-146a is upregulated in the peripheral blood mononuclear cells of patients with inter-critical gout when compared to normouricemic and hyperuricemic controls and those patients with acute gout flares. However, the role of miR-146a in the development of gout remains unknown. Here, we used miR-146a knockout (KO) mice to test miR-146a function in a monosodium urate (MSU)-induced gouty arthritis model. METHODS: The footpad or ankle joint of miR-146a KO and wild-type (WT) mice were injected with an MSU suspension to induce acute gouty arthritis. Bone marrow-derived macrophages (BMDMs) were stimulated with MSU and the gene expression of miR-146a; interleukin 1 beta (IL-1β); tumor necrosis factor-α (TNF-α); and the NACHT, LRR and PYD domains-containing protein 3 (NALP3) inflammasome was evaluated. TNF-α and IL-1β protein levels in BMDMs were assessed by fluorescence-activated cell sorting and western blot analyses. Gene and protein levels of TNF receptor-associated factor 6 (TRAF6) and IL-1 receptor-associated kinase (IRAK1), the targets of miR-146a, were also measured. RESULTS: Significantly increased paw swelling and index and ankle joint swelling were observed in miR-146a KO mice compared to WT controls after MSU treatment. MiR-146a expression in BMDMs from WT mice was dramatically upregulated at 4 h following MSU stimulation. Additionally, the expression of IL-1β, TNF-α, and NALP3 was higher in BMDMs from miR-146a KO mice after exposure to MSU crystals compared to those from WT mice. Consistent with the observed gene expression, the IL-1β and TNF-α proteins were upregulated in miR-146a KO mice. Additionally quantitative RT-PCR and western blot demonstrated that TRAF6 and IRAK1 were dramatically upregulated in BMDMs from miR-146 KO mice compared to those from WT mice. CONCLUSIONS: Collectively, these observations suggest that miR-146a provides negative feedback regulation of gouty arthritis development and lack of miR-146a enhances gouty arthritis via upregulation of TRAK6, IRAK-1, and the NALP3 inflammasome function. BioMed Central 2018-03-15 2018 /pmc/articles/PMC5855987/ /pubmed/29544526 http://dx.doi.org/10.1186/s13075-018-1546-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Quan-Bo
Qing, Yu-Feng
Yin, Cong-Cong
Zhou, Li
Liu, Xian-shuang
Mi, Qing-Sheng
Zhou, Jing-Guo
Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome
title Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome
title_full Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome
title_fullStr Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome
title_full_unstemmed Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome
title_short Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome
title_sort mice with mir-146a deficiency develop severe gouty arthritis via dysregulation of traf 6, irak 1 and nalp3 inflammasome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855987/
https://www.ncbi.nlm.nih.gov/pubmed/29544526
http://dx.doi.org/10.1186/s13075-018-1546-7
work_keys_str_mv AT zhangquanbo micewithmir146adeficiencydevelopseveregoutyarthritisviadysregulationoftraf6irak1andnalp3inflammasome
AT qingyufeng micewithmir146adeficiencydevelopseveregoutyarthritisviadysregulationoftraf6irak1andnalp3inflammasome
AT yincongcong micewithmir146adeficiencydevelopseveregoutyarthritisviadysregulationoftraf6irak1andnalp3inflammasome
AT zhouli micewithmir146adeficiencydevelopseveregoutyarthritisviadysregulationoftraf6irak1andnalp3inflammasome
AT liuxianshuang micewithmir146adeficiencydevelopseveregoutyarthritisviadysregulationoftraf6irak1andnalp3inflammasome
AT miqingsheng micewithmir146adeficiencydevelopseveregoutyarthritisviadysregulationoftraf6irak1andnalp3inflammasome
AT zhoujingguo micewithmir146adeficiencydevelopseveregoutyarthritisviadysregulationoftraf6irak1andnalp3inflammasome